Answers are grounded in this paper and cite their sources.
Maternal-specific RSV Ab decline rapidly following birth. However, we provide evidence of protection against severe disease by RSV-matAb during the first 6-7 months. This suggests that boosting maternal-specific Ab by RSV vaccination may be a useful strategy to consider.
No takes yet. Share an insight, caveat, or question.
Ochola et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: